Advanced techniques in toxicity testing
Tune in to this episode where we explore how innovative assays and human-relevant cell models are transforming toxicity screening in drug development.
List view / Grid view
Tune in to this episode where we explore how innovative assays and human-relevant cell models are transforming toxicity screening in drug development.
A novel screening tool may increase the five-year survival rate of hepatocellular carcinoma patients to 90 percent.
Researchers have developed a 3D approach to improve the characterisation of pancreatic intraepithelial neoplasias.
As we move towards more generalised AI models, neural networks and natural language interfaces, we’re starting to see machine learning take the place of higher order reasoning and data analysis “sense making.” Traditional scientific inquiry has typically been about asking specific questions of a specific model system under specific conditions.…
Natural products play an underappreciated role in drug discovery. Tandem mass spectrometry (MS/MS)-based metabolomics coupled with machine learning is allowing new, highly diverse molecules from natural products to be identified, revealing bioactive compounds and pinpointing promising drug targets. The additional dimension provided by trapped ion mobility (TIMS) enables researchers to…
In this Q&A, Dr Gerard Wong elucidates the inflammatory capacity of fragmented viral components from the perspective of supramolecular self-organisation.
Researchers conducted a proteogenomic characterisation and found that drug exposure changes drug sensitivity.
The computer model enables a better understanding of how drugs affect fibroblasts and finds a promising candidate to prevent heart scarring.
The ML algorithm explores how genetic mutations collectively influence a tumour’s reaction to drugs impeding DNA replication.
Dr Ketan Patel, Clarivate, shares his insights about the use of Real-World Data and genomic biomarker data and discusses how researchers can use these to better detect and diagnose diseases.
Disruptions in TP53 and RB1 are key influencers that cause changes in the risk of mutations across chromosomes.
Data from protein analyses, combined with data from patient journals, enabled the discovery of proteins that predict disease progression.
Novel approaches to brain disorder diagnosis and treatment may be developed following a project to form a map of the mouse hippocampus.
A certain macrophage phenotype is more effective than another phenotype commonly used in cell therapy for infiltrating tumours.
Tune into this podcast to understand why researchers are turning to 3D Organoids and how organoids can be made ready for screening.